NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹41 Cr | ₹20 Cr | ₹50 Cr | ₹57 Cr | ₹8.12 Cr |
What is the latest Consolidated Net Profit of NGL FINECHEM ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹41 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹50 Cr |
Mar2021 | ₹57 Cr |
Mar2020 | ₹8.12 Cr |
How is Consolidated Net Profit of NGL FINECHEM Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹41 Cr | 101.67 | |
Mar2023 | ₹20 Cr | -59.05 | |
Mar2022 | ₹50 Cr | -11.91 | |
Mar2021 | ₹57 Cr | 597.03 | |
Mar2020 | ₹8.12 Cr | - |
Compare Consolidated Net Profit of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹792.7 Cr | -9.2% | 25.5% | -49.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,712.0 Cr | -1.2% | 1.3% | 5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,623.0 Cr | -2% | 1.3% | 45.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,285.0 Cr | 1.4% | 11.9% | 15.7% | Stock Analytics | |
CIPLA | ₹119,010.0 Cr | -0.6% | -2% | -1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,118.0 Cr | -1.2% | -6.7% | -8.4% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -9.2% |
25.5% |
-49.8% |
SENSEX | 0.1% |
1% |
2.6% |
You may also like the below Video Courses